Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid
- PMID: 2861523
- DOI: 10.1016/s0140-6736(85)90176-x
Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid
Abstract
The prophylactic effect of antibody to endotoxin core glycolipid was studied in surgical patients at high risk of gram-negative infection. At randomisation (on admission to intensive care unit), every 5 days thereafter, and at onset of septic shock, patients received plasma taken from donors before (control) or after immunisation with Escherichia coli J5, a mutant with only core determinants in its endotoxin. Gram-negative shock occurred in 15 of 136 controls and 6 of 126 J5 antibody recipients and related deaths in 9 of 136 and 2 of 126, respectively. J5 antibody was most effective in abdominal surgery patients, in whom shock occurred in 13 of 83 controls and 2 of 71 antibody recipients. Although antibody prophylaxis did not lower the infection rate, it prevented the serious consequences of gram-negative infections and thus improved the overall prognosis.
Similar articles
-
[Anti-endotoxin core glycolipid antibody: the preparation of immune serum of E. Coli J5].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Jun;16(6):358-60. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004. PMID: 15182450 Chinese.
-
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.J Infect Dis. 1988 Aug;158(2):312-9. doi: 10.1093/infdis/158.2.312. J Infect Dis. 1988. PMID: 3136210 Clinical Trial.
-
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli.N Engl J Med. 1982 Nov 11;307(20):1225-30. doi: 10.1056/NEJM198211113072001. N Engl J Med. 1982. PMID: 6752708 Clinical Trial.
-
Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.Prog Clin Biol Res. 1991;367:141-59. Prog Clin Biol Res. 1991. PMID: 1924424 Review.
-
[Bacterial endotoxins and their effects].Orv Hetil. 1998 Aug 16;139(33):1947-53. Orv Hetil. 1998. PMID: 9734211 Review. Hungarian.
Cited by
-
Immunological perspectives in prevention and treatment of nosocomial pneumonia.Intensive Care Med. 1992;18 Suppl 1:S35-8. doi: 10.1007/BF01752975. Intensive Care Med. 1992. PMID: 1640032 Review.
-
Bacterial meningitis: mechanisms of disease and therapy.Eur J Pediatr. 1995 Feb;154(2):85-96. doi: 10.1007/BF01991906. Eur J Pediatr. 1995. PMID: 7720755 Review.
-
A pilot study of an anti-endotoxin Ig-enriched bovine colostrum to prevent experimental sepsis.Innate Immun. 2021 Apr;27(3):266-274. doi: 10.1177/17534259211007538. Innate Immun. 2021. PMID: 33858243 Free PMC article.
-
Monoclonal antibodies in sepsis and septic shock.BMJ. 1992 Jan 18;304(6820):132-3. doi: 10.1136/bmj.304.6820.132. BMJ. 1992. PMID: 1571053 Free PMC article. No abstract available.
-
Passive immunity in prevention and treatment of infectious diseases.Clin Microbiol Rev. 2000 Oct;13(4):602-14. doi: 10.1128/CMR.13.4.602. Clin Microbiol Rev. 2000. PMID: 11023960 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources